Cited by 229Diabetes Management and ResearchDiabetes Treatment and ManagementPatient Safety and Medication Errors

The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.

Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies

Open access

Silbert, Richard, Salcido-Montenegro, Alejandro, Rodriguez-Gutierrez, Rene, Katabi, Abdulrahman, McCoy, Rozalina G.·2018·Current Diabetes Reports

DOI 10.1007/s11892-018-1018-0PMC PMC6117835

Open this paper in CoChat — free account

Abstract

Purpose of ReviewHypoglycemia is the most common and often treatment-limiting serious adverse effect of diabetes therapy. Despite being potentially preventable, hypoglycemia in type 2 diabetes incurs substantial personal and societal burden. We review the epidemiology of hypoglycemia in type 2 diabetes, discuss key risk factors, and introduce potential prevention strategies.Recent FindingsReported rates of hypoglycemia in type 2 diabetes vary widely as there is marked heterogeneity in how hypoglycemia is defined, measured, and reported. In randomized controlled trials, rates of severe hypoglycemia ranged from 0.7 to 12 per 100 person-years. In observational studies, hospitalizations or emergency department visits for hypoglycemia were experienced by 0.2 (patients treated without insulin or sulfonylurea) to 2.0 (insulin or sulfonylurea users) per 100 person-years. Patient-reported hypoglycemia is much more common. Over the course of 6 months, 1–4% non-insulin users reported need for medical attention for hypoglycemia; 1–17%, need for any assistance; and 46–58%, any hypoglycemia symptoms. Similarly, over a 12-month period, 4–17% of insulin-treated patients reported needing assistance and 37–64% experienced any hypoglycemic symptoms. Hypoglycemia is most common among older patients with multiple or advanced comorbidities, patients with long diabetes duration, or patients with a prior history of hypoglycemia. Insulin and sulfonylurea use, food insecurity, and fasting also increase hypoglycemia risk. Clinical decision support tools may help identify at-risk patients. Prospective trials of efforts to reduce hypoglycemia risk are needed, and there is emerging evidence supporting multidisciplinary interventions including treatment de-intensification, use of diabetes technologies, diabetes self-management, and social support.SummaryHypoglycemia among patients with type 2 diabetes is common. Patient-centered multidisciplinary care may help proactively identify at-risk patients and address the multiplicity of factors contributing to hypoglycemia occurrence.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s11892-018-1018-0

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315 · cited 3×
“…requiring third-party assistance occurred in 1.3% of empaglifozin-treated patients (vs. 1.5% in placebo group; median 3.1 years of observation), [34] 2.4% of liraglutide-treated patients (vs. 3.3% in placebo group; median 3.8 years of observation), [36] 2.1% of saxagliptin-treated patients (vs.…”
Influential
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07037-8 · Cited by 8,247
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629 · cited 2×
“These trials include EMPA-REG OUTCOME (empagliflozin),[34] CANVAS (canagliflozin),[35] LEADER (liraglutide),[36] SAVOR-TIMI 53 (saxagliptin),[37] TECOS (sitagliptin),[38] EXAMINE (alogliptin),[39] ELIXA (lixisenatide),[40] SUSTAIN-6 (semaglutide),[41] and DEVOTE (insulin degludec).”
Influential
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900 · cited 2×
“These trials include EMPA-REG OUTCOME (empagliflozin),[34] CANVAS (canagliflozin),[35] LEADER (liraglutide),[36] SAVOR-TIMI 53 (saxagliptin),[37] TECOS (sitagliptin),[38] EXAMINE (alogliptin),[39] ELIXA (lixisenatide),[40] SUSTAIN-6 (semaglutide),[41] and DEVOTE (insulin degludec).”
Influential
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762

Show all 126 references

Sorted by citations

6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2024
ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., Lingvay, I., et al. (2023) · Diabetes Care · doi:10.2337/dc24-s006 · Cited by 574
Self-citation
6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s006 · Cited by 440
Self-citation
Benefits and harms of intensive glycemic control in patients with type 2 diabetes
Rodriguez-Gutierrez, R., Gonzalez-Gonzalez, J. G., Zuñiga-Hernandez, J. A., & McCoy, R. G. (2019) · BMJ · doi:10.1136/bmj.l5887 · Cited by 152
Self-citation
Food Insecurity and Cardiometabolic Conditions: a Review of Recent Research
Te‐Vazquez, J., Feng, S. N., Orr, C. J., & Berkowitz, S. A. (2021) · Current Nutrition Reports · doi:10.1007/s13668-021-00364-2 · Cited by 150
Association of cumulative multimorbidity, glycemic control, and medication use with hypoglycemia-related emergency department visits and hospitalizations among adults with diabetes
McCoy, R. G., Lipska, K. J., Van Houten, H. K., & Shah, N. D. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.19099 · Cited by 141
Self-citation
6. Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises: Standards of Care in Diabetes-2026.
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s006 · Cited by 172
Self-citation
Prevalence and impact of polypharmacy in older patients with type 2 diabetes
Remelli, F., Ceresini, M. G., Trevisan, C., Noale, M., & Volpato, S. (2022) · Aging Clinical and Experimental Research · doi:10.1007/s40520-022-02165-1 · Cited by 140
Adoption of New Glucose-Lowering Medications in the U.S.—The Case of SGLT2 Inhibitors: Nationwide Cohort Study
McCoy, R. G., Dykhoff, H. J., Sangaralingham, L., Ross, J. S., Karaca-Mandic, P., Montori, V. M., & Shah, N. D. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0213 · Cited by 122
Self-citation
Alzheimer’s disease as type 3 diabetes: understanding the link and implications
Kciuk, M., Kruczkowska, W., Gałęziewska, J., Wanke, K., Kałuzińska-Kołat, Ż., Aleksandrowicz, M., & Kontek, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211955 · Cited by 98
Type 2 diabetes mellitus and cognitive function: understanding the connections
Dao, L., CHOI, S. E., & Freeby, M. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000783 · Cited by 82
SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes
Kim, H., Biessels, G. J., Yu, M. H., Hong, N., Lee, Y., Lee, B., Kang, E. S., Soo, B., Lee, E. J., & Lee, M. (2024) · Neurology · doi:10.1212/wnl.0000000000209805 · Cited by 73
Society for Ambulatory Anesthesia Updated Consensus Statement on Perioperative Blood Glucose Management in Adult Patients With Diabetes Mellitus Undergoing Ambulatory Surgery
Rajan, N., Duggan, E. W., Abdelmalak, B., Butz, S. F., Rodriguez, L. V., Vann, M. A., & Joshi, G. P. (2024) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006791 · Cited by 75
Nutritional guidelines for the management of insulin resistance
Muscogiuri, G., Barrea, L., Caprio, M., Ceriani, F., Chavez, A. O., El Ghoch, M., Frias-Toral, E., Mehta, R. J., Mendez, V., Paschou, S. A., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1908223 · Cited by 63
Incidence and prevalence of hypoglycaemia in type 1 and type 2 diabetes individuals: A systematic review and meta-analysis
Alwafi, H. H., Alsharif, A. A., Wei, L., Langan, D., Naser, A. Y., Mongkhon, P., Bell, J. S., Ilomäki, J., AlMetwazi, M. S., Man, K. K. C., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108522 · Cited by 54
Paradox of glycemic management: multimorbidity, glycemic control, and high-risk medication use among adults with diabetes
McCoy, R. G., Lipska, K. J., Van Houten, H. K., & Shah, N. D. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001007 · Cited by 51
Self-citation
Diabetes education impact on hypoglycemia outcomes: a systematic review of evidence and gaps in the literature
LaManna, J., Litchman, M. L., Dickinson, J. K., Todd, A., Julius, M. M., Whitehouse, C. R., Hyer, S., & Kavookjian, J. (2019) · The Diabetes Educator · doi:10.1177/0145721719855931 · Cited by 50
Metformin: A Narrative Review of Its Potential Benefits for Cardiovascular Disease, Cancer and Dementia
Top, W. M. C., Kooy, A., & Stehouwer, C. D. A. (2022) · Pharmaceuticals · doi:10.3390/ph15030312 · Cited by 51
Association between hypoglycemia and dementia in patients with diabetes: a systematic review and meta-analysis of 1.4 million patients
Huang, L., Zhu, M., & Ji, J. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00799-9 · Cited by 46
A Systematic Review Supporting the Endocrine Society Guidelines: Management of Diabetes and High Risk of Hypoglycemia
Roldan, V. D. T., Urtecho, M., Nayfeh, T., Firwana, M., Muthusamy, K., Hasan, B., Abd‐Rabu, R., Maraboto, A., Qoubaitary, A., Prokop, L. J., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac601 · Cited by 46
Use of Potentially Nephrotoxic Medications by U.S. Adults with Chronic Kidney Disease: NHANES, 2011–2016
Kurani, S. S., Jeffery, M. M., Thorsteinsdottir, B., Hickson, L. J., Barreto, E. F., Haag, J. D., Giblon, R. E., Shah, N. D., & McCoy, R. G. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-05557-8 · Cited by 42
Self-citation
Nocturnal hypoglycemia is underdiagnosed in older people with insulin‐treated type 2 diabetes: The HYPOAGE observational study
Boureau, A., Guyomarch, B., Gourdy, P., Allix, I., Annweiler, C., Cervantes, N., Chapelet, G., Delabrière, I., Guyonnet, S., Litke, R. R., et al. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18341 · Cited by 41
Hypoglycemic episodes are associated with an increased risk of incident frailty among new onset diabetic patients
Chao, C., Wang, J., Huang, J., Chan, D., & Chien, K. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.107492 · Cited by 39
Prevalence of Hypoglycemia Among Patients With Type 2 Diabetes Mellitus in a Rural Health Center in South India
Samya, V., Shriraam, V., Jasmine, A., Venguidesvarane, A. G., Rani, M. A., Durai, V., Gayathri, T., & Mahadevan, S. (2019) · Journal of Primary Care & Community Health · doi:10.1177/2150132719880638 · Cited by 45
A novel electronic health record-based, machine-learning model to predict severe hypoglycemia leading to hospitalizations in older adults with diabetes: A territory-wide cohort and modeling study
Shi, M., Yang, A., Lau, E. S. H., Luk, A. O. Y., Ronald, C. W., Kong, A. P. S., Wong, R. S. M., Chan, J. C. M., Chan, J. C. N., & Chow, E. (2024) · PLoS Medicine · doi:10.1371/journal.pmed.1004369 · Cited by 37
Generalization of a Deep Learning Model for Continuous Glucose Monitoring–Based Hypoglycemia Prediction: Algorithm Development and Validation Study
Shao, J., Liu, Z., Li, S., Feng, H., Li, J., Nie, Z., Pan, Y., Feng, H., Li, Y., Yang, L., et al. (2024) · JMIR Medical Informatics · doi:10.2196/56909 · Cited by 40
Patient Perceptions of Diabetes Guideline Frameworks for Individualizing Glycemic Targets
Schoenborn, N. L., Crossnohere, N. L., Bridges, J. F. P., Pollack, C. E., Pilla, S. J., & Boyd, C. M. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.3806 · Cited by 30
Nutritional management of type 2 diabetes in subjects with obesity: an international guideline for clinical practice
Barrea, L., Vetrani, C., Caprio, M., Ghoch, M. E., Frías-Toral, E., Mehta, R. J., Méndez, V., Moriconi, E., Paschou, S. Α., Pazderska, A., et al. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1980766 · Cited by 30
Predicting Risk of Hypoglycemia in Patients With Type 2 Diabetes by Electronic Health Record–Based Machine Learning: Development and Validation
Yang, H., li, J., Liu, S., Yang, X., & Liu, J. (2022) · JMIR Medical Informatics · doi:10.2196/36958 · Cited by 30
Multimorbidity, Polypharmacy, Severe Hypoglycemia, and Glycemic Control in Patients Using Glucose-Lowering Drugs for Type 2 Diabetes: A Retrospective Cohort Study Using Health Insurance Claims in Japan
Koto, R., Nakajima, A., Miwa, T., & Sugimoto, K. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01421-5 · Cited by 30
Effective Treatment Recommendations for Type 2 Diabetes Management Using Reinforcement Learning: Treatment Recommendation Model Development and Validation
Sun, X., Bee, Y. M., Lam, S. W., Liu, Z., Zhao, W., Chia, S. Y., Kadir, H. B. A., Wu, J. T., Ang, B. Y., Liu, N., et al. (2021) · Journal of Medical Internet Research · doi:10.2196/27858 · Cited by 29
Glucagon prescribing and costs among U.S. Adults with diabetes, 2011–2021
Herges, J. R., Galindo, R. J., Neumiller, J. J., Heien, H. C., Umpierrez, G. E., & McCoy, R. G. (2023) · Diabetes Care · doi:10.2337/dc22-1564 · Cited by 28
Self-citation
Deintensification of Treatment With Sulfonylurea and Insulin After Severe Hypoglycemia Among Older Adults With Diabetes
Alexopoulos, A., Kahkoska, A. R., Pate, V., Bradley, M. C., Niznik, J. D., Thorpe, C. T., Stürmer‎, T., & Buse, J. B. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.32215 · Cited by 28
The Other Face of Insulin—Overdose and Its Effects
Rzepczyk, S., Dolińska-Kaczmarek, K., Uruska, A. A., & Żaba, C. (2022) · Toxics · doi:10.3390/toxics10030123 · Cited by 28
An update on the current characteristics and status of care for Muslims with type 2 diabetes fasting during Ramadan: the DAR global survey 2022
Hassanein, M., Zainudin, S. B., Shaikh, S. S., Shaltout, I., Malek, R., Büyükbeşe, M. A., Alfadhli, E. M., Shaikh, K. A., Hussein, Z. B., Eliana, F., et al. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2385057 · Cited by 26
Drug-induced hypoglycemia: a disproportionality analysis of the FAERS database
Li, J., Wang, Y., Yang, X., Zhu, H., & Jiang, Z. (2023) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2023.2278700 · Cited by 27
Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement
Kalyani, R. R., Allende-Vigo, M. Z., Antinori-Lent, K. J., Close, K. L., Das, S. R., Deroze, P., Edelman, S. V., El Sayed, N. A., Kerr, D., Neumiller, J. J., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad745 · Cited by 25
Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial
Pieber, T. R., Arfelt, K. N., Cailleteau, R., Hart, M., Kar, S., Mursic, I., Švehlíková, E., Urschitz, M., & Haahr, H. L. (2023) · Diabetologia · doi:10.1007/s00125-023-05921-8 · Cited by 25
The present and future scope of real‐world evidence research in diabetes: What questions can and cannot be answered and what might be possible in the future?
Zaccardi, F., Davies, M. J., & Khunti, K. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13929 · Cited by 22
Low glycaemic state increases risk of frailty and functional decline in older people with type 2 diabetes mellitus – Evidence from a systematic review
Abdelhafiz, A. H., Peters, S., & Sinclair, A. J. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.109085 · Cited by 22
Association Between the CYP2C9 Genotype and Hypoglycemia Among Patients With Type 2 Diabetes Receiving Sulfonylurea Treatment: A Meta-analysis
Yee, J., Heo, Y., Kim, H., Yoon, H. Y., Song, G., & Gwak, H. S. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.03.008 · Cited by 21
Strains of Faecalibacterium prausnitzii and its extracts reduce blood glucose levels, percent HbA1c, and improve glucose tolerance without causing hypoglycemic side effects in diabetic and prediabetic mice
Kallassy, J., Gagnon, E., Rosenberg, D. A., Silbart, L. K., & McManus, S. A. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003101 · Cited by 20
Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes
Farngren, J., & Åhrén, B. (2019) · Metabolism · doi:10.1016/j.metabol.2019.06.016 · Cited by 20
Impact of High Deductible Health Plans on Diabetes Care Quality and Outcomes: Systematic Review
Jiang, D. H., Mundell, B. F., Shah, N. D., & McCoy, R. G. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.07.001 · Cited by 20
Self-citation
Medication Prescribing for Type 2 Diabetes in the US Long-Term Care Setting: Observational Study
Pandya, N., Jung, M., Norfolk, A., Goldblatt, C. M., Trenery, A., & Sieradzan, R. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2023.03.020 · Cited by 19
Older Adults Benefit From Virtual Support for Continuous Glucose Monitor Use But Require Longer Visits
Weinstock, R. S., Raghinaru, D., Gal, R. L., Bergenstal, R. M., Bradshaw, A., Cushman, T., Kollman, C., Kruger, D. F., Johnson, M. L., MCARTHUR, T. S., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241294250 · Cited by 18
Impact of fear of hypoglycaemia on self-management in patients with type 2 diabetes mellitus: structural equation modelling
Li, S., Li, Y., Zhang, L., Bi, Y., Zou, Y., Liu, L., Zhang, H., Yuanyuan, Gong, W., & Zhang, Y. (2022) · Acta Diabetologica · doi:10.1007/s00592-021-01839-y · Cited by 20
Prevalence and predictors of hypoglycemia in older outpatients with type 2 diabetes mellitus
Al‐Azayzih, A., Kanaan, R. J., Altawalbeh, S. M., Alzoubi, K. H., Kharaba, Z. J., & Jarab, A. S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309618 · Cited by 22
Development and validation of a prediction model of perioperative hypoglycemia risk in patients with type 2 diabetes undergoing elective surgery
Han, H., Lai, J., Yan, C., Li, X., Hu, S., He, Y., & Li, H. (2022) · BMC Surgery · doi:10.1186/s12893-022-01601-3 · Cited by 17
Identifying Common Predictors of Multiple Adverse Outcomes Among Elderly Adults With Type-2 Diabetes
Kabue, S., Liu, V. X., Dyer, W., Raebel, M. A., Nichols, G. A., & Schmittdiel, J. A. (2019) · Medical Care · doi:10.1097/mlr.0000000000001159 · Cited by 16
Prevalence and contributing factors of impaired awareness of hypoglycemia in patients with type 2 diabetes: a meta-analysis
Li, X., Kan, Y., Liu, H.-Y., Pang, J., He, Y., Liu, L., Zou, Y., Zhang, N., & Zhang, Y. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02102-2 · Cited by 16
Type 2 diabetes in older patients: an analysis of the DPV and DIVE databases
van Mark, G., Tittel, S. R., Sziegoleit, S., Putz, F. J., Durmaz, M., Bortscheller, M., Buschmann, I. R., Seufert, J., Holl, R. W., & Bramlage, P. (2020) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820958296 · Cited by 14
Nutritional intervention for diabetes mellitus with Alzheimer's disease
Li, Z., Li, S., Xiao, Y., Zhong, T., Yu, X., & Wang, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1046726 · Cited by 12
The Role of Platelets in Hypoglycemia-Induced Cardiovascular Disease: A Review of the Literature
Ali, A. A. G., Niinuma, S. A., Moin, A. S. M., Atkin, S. L., & Butler, A. E. (2023) · Biomolecules · doi:10.3390/biom13020241 · Cited by 13
Exploring determinants of sex and family history-based disparity in type 2 diabetes mellitus prevalence among clinical patients
Alrashed, F. A., Iqbal, M., Alsubiheen, A. M., & Ahmad, T. (2024) · BMC Public Health · doi:10.1186/s12889-024-18170-0 · Cited by 20
Integrating Illness Management Into Identity Verification Processes
Maietta, J. T. (2020) · Qualitative Health Research · doi:10.1177/1049732320966582 · Cited by 13
Efficacy and Safety of Dapagliflozin versus Liraglutide in Patients with Overweight or Obesity and Type 2 Diabetes Mellitus: A Randomised Controlled Clinical Trial in Tianjin, China
Hao, Z., Xiao, H., Shao, H., & Feng, H. (2022) · Journal of Diabetes Research · doi:10.1155/2022/4126995 · Cited by 13
The relationship between components of hypoglycemia worries and avoiding hypoglycemia behavior in type 2 diabetes mellitus with hypoglycemia: a network analysis
Wu, C., Wang, W., Cheng, S., Zhang, H., Li, L., Tian, C., Zhang, L., Chen, N., Du, J., Ren, L., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04698-9 · Cited by 12
Development and Validation of a Hypoglycemia Risk Model for Intensive Insulin Therapy in Patients with Type 2 Diabetes
Hu, X., Xu, W., Lin, S., Zhang, C., Ling, C., & Chen, M. (2020) · Journal of Diabetes Research · doi:10.1155/2020/7292108 · Cited by 13
Central and peripheral neural circuits regulating glucose homeostasis
Espinoza, D., Seibold, F., & Stanley, S. A. (2025) · npj Biomedical Innovations. · doi:10.1038/s44385-025-00036-8 · Cited by 13
Factors Associated With Hospitalization for Hypoglycemia and Hyperglycemia Among Older People in Long‐Term Care Facilities
Wondimkun, Y. A., Caughey, G. E., Inacio, M. C. S., Air, T., Lang, C. E., Hogan, M., & Sluggett, J. K. (2025) · Journal of the American Geriatrics Society · doi:10.1111/jgs.19553 · Cited by 11
Incidence of severe hypoglycemia and its association with serum adiponectin in Japanese patients with type 1 and insulin‐treated type 2 diabetes: The Fukuoka Diabetes Registry
Iwase, M., Komorita, Y., Fujii, H., Ohkuma, T., Ide, H., Yoshinari, M., Oku, Y., Higashi, T., Nakamura, U., & Kitazono, T. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13253 · Cited by 11
Reproductive Life Span and Severe Hypoglycemia Risk in Postmenopausal Women with Type 2 Diabetes Mellitus
Kang, S. Y., Park, Y., Kwon, D. J., Chung, Y., Namkung, J., Han, K., & Ko, S. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0135 · Cited by 12
Management and Outcomes of Severe Hypoglycemia Treated by Emergency Medical Services in the U.S. Upper Midwest
Myers, L. A., Swanson, K. M., Glasgow, A. E., & McCoy, R. G. (2022) · Diabetes Care · doi:10.2337/dc21-1811 · Cited by 11
Self-citation
Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus
Chen, L., Tang, Y., Huang, J., Liu, S., & Xing, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.975468 · Cited by 10
Documentation of hypoglycemia assessment among adults with diabetes during clinical encounters in primary care and endocrinology practices
on behalf of the Hypoglycemia as a Quality Measure in Diabetes Study Group, Rodríguez‐Gutiérrez, R., Salcido‐Montenegro, A., Ospina, N. S., Maraka, S., Iñiguez‐Ariza, N. M., Spencer‐Bonilla, G., Tamhane, S. U., Lipska, K. J., Montori, V. M., et al. (2019) · Endocrine · doi:10.1007/s12020-019-02147-w · Cited by 11
Self-citation
Association between reduced kidney function and incident hypoglycaemia in people with diabetes: The Stockholm Creatinine Measurements ( SCREAM ) project
Runesson, B., Xu, Y., Qureshi, A. R., Lindholm, B., Barany, P. F., Elinder, C. G., & Carrero, J. J. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14051 · Cited by 11
Regional disparities in health literacy for chronic diseases: focusing on healthcare resources and local extinction index
Ji, S., Kwon, Y. G., Lee, H., Shin, C., Sohn, M., & Choi, M. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1423645 · Cited by 10
Predictive factors of hypoglycemia in type 2 diabetes: a prospective study using machine learning
Shabestari, M., Mehrabbeik, A., Barbieri, S., Marques-Vidal, P. M., Heshmati-Nasab, P., & Azizi, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-03030-7 · Cited by 14
Real-World Effectiveness of the MiniMed™ 780G Advanced Hybrid Closed-Loop System for People ≥65 Years with Type 1 or Type 2 Diabetes in the United States
Chien, A., Shin, J., Liu, M., Arrieta, A., Cordero, T. L., Swensen, A. R., & Vigersky, R. A. (2025) · Diabetes Technology & Therapeutics · doi:10.1177/15209156251376654 · Cited by 11
A Cross-Sectional study on risk factors for severe hypoglycemia among Insulin-Treated elderly type 2 diabetes Mellitus (T2DM) patients in Singapore
Ko, M. S. M., Lee, W. K., Ang, L. C., Goh, S., Bee, Y. M., & Teh, M. M. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109236 · Cited by 11
Hypoglycemia in Older People With Type 2 Diabetes: Prevention and Treatment Strategies for Outpatient and Long-Term Care Facility Settings
Nguyen, J. V., Roseberry, S., Rivas, J. A., & Cauthon, K. A. B. (2021) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2021.112 · Cited by 10
Type 2 diabetes patients’ views on prevention of hypoglycaemia – a mixed methods study investigating self-management issues and self-identified causes of hypoglycaemia
Crutzen, S., van den Born-Bondt, T., Denig, P., & Taxis, K. (2021) · BMC Family Practice · doi:10.1186/s12875-021-01466-0 · Cited by 10
New Developments in Glucagon Treatment for Hypoglycemia
Hayward, L., & Wilson, L. M. (2022) · Drugs · doi:10.1007/s40265-022-01754-8 · Cited by 11
G6 continuous glucose monitoring system feature use and its associations with glycaemia in Europe
Acciaroli, G., Parkin, C. G., Thomas, R., Layne, J. E., Norman, G. J., & Leone, K. (2023) · Diabetic Medicine · doi:10.1111/dme.15093 · Cited by 11
Low ambient temperatures correlate with increased risk of hypoglycemia in patients with type 2 diabetes
Lai, S., Chang, W.-C., Lin, C., Chou, I., Tsai, F., & Lai, Y. (2020) · Medicine · doi:10.1097/md.0000000000019287 · Cited by 10
Predictors of consciousness improvement in patients with hypoglycemic encephalopathy
Lee, Y. E., Lee, E. J., Lee, S. E., & Park, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.956367 · Cited by 9
SERS profiling of blood serum filtrate components from patients with type II diabetes using 100 kDa filtration devices
Shoukat, Z., Atta, R., Majeed, M. I., Nawaz, H., Rashid, N., Alshammari, A., Albekairi, N. A., Shahzadi, A., Yaseen, S., Tahir, A., et al. (2025) · RSC Advances · doi:10.1039/d4ra06335j · Cited by 9
Epidemiological, Social and Economic Burden of Severe Hypoglycaemia in Patients with Diabetes Mellitus in Portugal: A Structured Literature Review
Soares, A. R., Coelho, M., Tracey, M., Carvalho, D. M., & Silva‐Nunes, J. (2023) · Diabetes Therapy · doi:10.1007/s13300-022-01358-1 · Cited by 10
Next-Day Prediction of Hypoglycaemic Episodes Based on the Use of a Mobile App for Diabetes Self-Management
Alexiadis, A., Tsanas, A., Shtika, L., Efopoulos, V., Votis, K., Tzovaras, D. K., & Triantafyllidis, A. K. (2024) · IEEE Access · doi:10.1109/access.2024.3350201 · Cited by 9
Sociodemographic Factors Associated with Participation in Diabetes Education among Community-Dwelling Adults with Diabetes
Lee, Y. H. (2020) · Yonsei Medical Journal · doi:10.3349/ymj.2020.61.2.169 · Cited by 9
Identifying Patients With Hypoglycemia Using Natural Language Processing: Systematic Literature Review
Zheng, Y., Dickson, V. V., Blecker, S., Ng, J. M., Rice, B. C., Melkus, G. D., Shenkar, L., Mortejo, M. C. R., & Johnson, S. B. (2022) · JMIR Diabetes · doi:10.2196/34681 · Cited by 10
Clinical characteristics and influencing factors of hypoglycemia in hospitalized patients with type 2 diabetes mellitus: A cross‐sectional study
Li, M., Zhao, M., Yan, H., Guo, H., & Shi, B. (2023) · Nursing Open · doi:10.1002/nop2.1929 · Cited by 9
Qualitative analysis of reasons for hospitalization for severe hypoglycemia among older adults with diabetes
Pasciak, W., Berg, D. N., Cherlin, E. J., Fried, T. R., & Lipska, K. J. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02268-w · Cited by 10
Validity of an ICD-10 Coding Algorithm for Acute Heat Illness in the Emergency Department: A Retrospective Cohort Study
Baassiri, H., Varghese, T., Clemens, K. K., Ouédraogo, A. M., Aarsen, K. V., Vujčić, B., & Yan, J. W. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21091132 · Cited by 8
Fasting biochemical hypoglycemia and related-factors in non-diabetic population: Kanagawa Investigation of Total Check-up Data from National Database-8
Tanaka, K., Higuchi, R., Mizusawa, K., Nakamura, T., & Nakajima, K. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i7.1131 · Cited by 8
Effectiveness of interventions for emergency care of hypoglycaemia and diabetic ketoacidosis: A systematic review
Maharjan, J., Pandit, S., Johansson, K. A., Khanal, P., Karmacharya, B. M., Kaur, G., & Aryal, K. K. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.111078 · Cited by 8
Medication-Related Hospital Admissions and Emergency Department Visits in Older People with Diabetes: A Systematic Review
Vonna, A., Salahudeen, M. S., & Peterson, G. M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13020530 · Cited by 10
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials
Mellor, J., Kuznetsov, D., Heller, S. R., Gall, M.-A., Rosilio, M., Amiel, S. A., Ibberson, M. R., McGurnaghan, S. J., Blackbourn, L. A. K., Berthon, W., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06177-6 · Cited by 8
Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin‐treated type 2 diabetes: Results from a real‐world nested case‐control study
Settles, J. A., Kan, H. J., Child, C. J., Gorritz, M., Multani, J. K., McGuiness, C. B., Wade, R. L., & Frier, B. M. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14690 · Cited by 7
Dual Detection of Glucose Using Commercial Potassium Permanganate and Glucose Oxidase: Colorimetric and Absorbance-Based Approaches
Hoang, C. N. M., Nguyen, S. H., & Tran, M. T. (2025) · ACS Omega · doi:10.1021/acsomega.5c03564 · Cited by 7
Prediction of Hypoglycemia in Diabetic Patients During Colonoscopy Preparation
Lü, X., Xie, L., Zhao, W., Zhang, C., Luo, X., & Zhou, Y. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2044-0685 · Cited by 7
Fracture risk in patients with type 2 diabetes aged ≥50 years related to HbA1c, acute complications, BMI and SGLT2i-use in the DPV registry
Eckert, A. J., Mader, J. K., Altmeier, M., Mühldorfer, S., Gillessen, A., Dallmeier, D., Shah, V. N., Heyer, C. H. J., Hartmann, B., & Holl, R. W. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107664 · Cited by 7
A Practical Guide on Behaviour Change Support for Self-Managing Chronic Disease
Guerreiro, M. P., Félix, I. B., & Marques, M. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-20010-6 · Cited by 8
Economic Burdens of Type 2 Diabetes Hospital Visits with Hypoglycemic Episodes in the Tertiary Care Setting in Thailand
Kosachunhanun, N., Wongsa, D., & Permsuwan, U. (2023) · Healthcare · doi:10.3390/healthcare11070949 · Cited by 7
Disturbed hippocampal histidine metabolism contributes to cognitive impairment induced by recurrent nonsevere hypoglycemia in diabetes
Wu, K., Xie, W., Zhou, C., Zhou, L., Wang, L., Zhou, Y., & Liu, L. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.10.036 · Cited by 7
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review
Kiconco, R., Lumumba, S. A., Bagenda, C. N., Atwine, R., Ndarubweine, J., & Rugera, S. P. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241232280 · Cited by 6
Construction and validation of a hypoglycemia risk prediction model for hospitalized type 2 diabetes patients based on machine learning
Liu, C., Huang, Z., Liu, T., Ge, Y., Yuan, J., Lin, Y., Wang, C., Zhang, J., Wang, X., Hua, Y., et al. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02104-x · Cited by 6
The association of cardiometabolic multimorbidity with depression and length of hospitalization: a population-based cross-sectional study among adults in Turkey
Köse, A., Arayıcı, M., & Şimşek, H. (2025) · BMC Public Health · doi:10.1186/s12889-025-23306-x · Cited by 3
Hypoglycemia unawareness identified by continuous glucose monitoring system is frequent in outpatients with type 2 diabetes without receiving intensive therapeutic interventions
Huang, B., Jiang, Q., Wu, T., Shen, Q., Wang, W., Wang, S., Huang, Y., Wang, S., Huang, P., Lin, M., et al. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00959-x · Cited by 7
Association of hypoglycemic events with cognitive impairment in patients with type 2 diabetes mellitus: Protocol for a dose-response meta-analysis
Ye, M., Yuan, A. H., Yang, Q. Q., Li, Q., Li, F. Y., & Wei, Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296662 · Cited by 6

Authors: Silbert, R., Salcido-Montenegro, A., Rodriguez-Gutierrez, R., Katabi, A., & McCoy, R. G.
Affiliations: Mayo Clinic (US)
Corresponding author: McCoy, Rozalina G.
ORCID: Katabi, Abdulrahman
McCoy, Rozalina G.
Venue: Current Diabetes Reports
Publisher: Springer Science and Business Media LLC
Published: 2018-06-21
Volume: 18
Issue: 8
Pages: 53-53
ISSN: 1534-4827 (ISSN-L)
1539-0829
DOI: 10.1007/s11892-018-1018-0
PMC: PMC6117835
OpenAlex: W2809031508
Semantic Scholar: d6d2b9f681259ecdf86d479f18c51145da848f3e
Cited by: 229
References: 126
Citations by year: 2026: 15 · 2025: 34 · 2024: 42 · 2023: 47 · 2022: 36 · 2021: 24 · 2020: 15 · 2019: 14 · 2018: 1
FWCI: 2.08
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Current Diabetes Reports (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Mayo Clinic
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK114497)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
Keywords: hypoglycemia, type 2 diabetes, hypoglycemia risk factors, hypoglycemia prevention, insulin therapy, sulfonylureas, food insecurity, fasting, diabetes duration, comorbidities, clinical decision support, treatment deintensification, diabetes self-management, diabetes technology, multidisciplinary care
MeSH terms: Blood Glucose, Diabetes Mellitus, Type 2, Humans, Hypoglycemia, Risk Factors, Randomized Controlled Trials as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks